What you need to know about Monoclonal Antibody Therapy treatment for COVID-19 patients

Patients recently diagnosed with COVID-19 now have a treatment option that may help speed up their recovery process and lower their chances of being admitted to the hospital.

Monoclonal Antibody Therapy is an investigational treatment approved by the U.S. Food and Drug Administration to treat COVID-19 pediatric and adult patients experiencing mild to moderate symptoms.

In this video, Augusta University Health‘s Chief Medical Officer Dr. Phillip Coule shares what you need to know about Monoclonal Antibody Therapy and more important facts about the coronavirus.

Visit AU Health’s Virtual Care to find out if you qualify for this treatment, and keep up with the latest COVID-19 news and statistics here.

Like Love Haha Wow Sad Angry
Written by
Danielle Harris

Danielle Harris is Senior Media Relations Coordinator at Augusta University. Contact her to schedule an interview on this topic or with one of our experts at 706-721-7511 or deharris1@augusta.edu.

View all articles
Written by Danielle Harris

Jagwire is your source for news and stories from Augusta University and AU Health. Daily updates highlight the many ways students, faculty, staff, researchers and clinicians "bring their A games" in classrooms and clinics on four campuses in Augusta and locations across the state of Georgia.

Read on for stories of innovation in education and health care, opportunities at the center of Georgia’s new cybersecurity hub, and experiential learning that blends arts and application, humanities and the health sciences.